PMID- 32825345 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201028 IS - 2077-0383 (Print) IS - 2077-0383 (Electronic) IS - 2077-0383 (Linking) VI - 9 IP - 9 DP - 2020 Aug 20 TI - Early Valve Replacement for Severe Aortic Valve Disease: Effect on Mortality and Clinical Ramifications. LID - 10.3390/jcm9092694 [doi] LID - 2694 AB - Timing of aortic valve intervention for chronic aortic regurgitation (AR) and/or aortic stenosis (AS) potentially affects long-term survival. The 2014 American Heart Association/American College of Cardiology (AHA/ACC) guidelines provide recommendations for the timing of intervention. Subsequent to the guidelines' release, several studies have been published that suggest a survival benefit from earlier timing of surgery for severe AR and/or AS. The aim of this review was to determine whether patients who have chronic aortic regurgitation (AR) and/or aortic stenosis (AS) have a survival benefit from earlier timing of aortic valve surgery. Medical databases were systematically searched from January 2015 to April 2020 for randomized controlled trials (RCTs) and observational studies that examined the timing of aortic valve replacement surgery for chronic AR and/or AS. For chronic AR, four observational studies and no RCTs were identified. For chronic AS, five observational studies, one RCT and one meta-analysis were identified. One observational study examining mixed aortic valve disease (MAVD) was identified. All of these studies, for AR, AS, and MAVD, found long-term survival benefit from timing of aortic valve surgery earlier than the current guidelines. Larger prospective RCTs are required to evaluate the benefit of earlier surgical intervention. FAU - Koerber, Jason P AU - Koerber JP AD - Department of Anaesthesia, Flinders Medical Centre, Adelaide, SA 5042, Australia. FAU - Bennetts, Jayme S AU - Bennetts JS AD - Department of Cardiac and Thoracic Surgery, Flinders Medical Centre, Adelaide, SA 5042, Australia. AD - College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia. FAU - Psaltis, Peter J AU - Psaltis PJ AD - Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5000, Australia. AD - Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia. AD - Department of Cardiology, Central Adelaide Local Health Network, Adelaide, SA 5000, Australia. LA - eng PT - Journal Article PT - Review DEP - 20200820 PL - Switzerland TA - J Clin Med JT - Journal of clinical medicine JID - 101606588 PMC - PMC7563468 OTO - NOTNLM OT - aortic regurgitation OT - aortic stenosis OT - aortic valve replacement OT - mixed aortic valve disease OT - survival OT - transcatheter aortic valve implantation OT - valvular heart disease COIS- P.J.P. receives a L2 Future Leader Fellowship from the National Heart Foundation of Australia (FLF102056) and L2 Career Development Fellowship from the NHMRC (CDF11615reproduce06). P.J.P. has received research support from Abbott Vascular, consulting fees from Amgen and Esperion and travel or speaker honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, Merck Schering-Plough and Pfizer. J.S.B. is an Advisor for Medtronic, Abbott Vascular, and Edwards Lifesciences and has received travel, research, and/or speaking honoraria from Medtronic and Edwards Lifesciences. EDAT- 2020/08/23 06:00 MHDA- 2020/08/23 06:01 PMCR- 2020/08/20 CRDT- 2020/08/23 06:00 PHST- 2020/07/14 00:00 [received] PHST- 2020/08/17 00:00 [revised] PHST- 2020/08/18 00:00 [accepted] PHST- 2020/08/23 06:00 [entrez] PHST- 2020/08/23 06:00 [pubmed] PHST- 2020/08/23 06:01 [medline] PHST- 2020/08/20 00:00 [pmc-release] AID - jcm9092694 [pii] AID - jcm-09-02694 [pii] AID - 10.3390/jcm9092694 [doi] PST - epublish SO - J Clin Med. 2020 Aug 20;9(9):2694. doi: 10.3390/jcm9092694.